Differential effect of dexamethasone and hydrocortisone on alveolar growth in rat pups

Pediatric Pulmonology

Volumn 33, Issue 6, 2002, Pages 443-448

  Fayon, Michael ^a,b   Jouvencel, Philippe ^a,b   Carles, Dominique ^a   Choukroun, Marie Luce ^b   Marthan, Roger ^b  

^a HÔPITAL PELLEGRIN   (France)

^b INSERM   (France)

Author keywords

Animal models; Bronchopulmonary dysplasia; Corticosteroids; Growth; Lung; Rats; Respiratory distress syndrome

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HISTOLOGY; LUNG ALVEOLUS; LUNG DEVELOPMENT; LUNG DYSPLASIA; LUNG VOLUME; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY DISTRESS SYNDROME;

ANIMALS; ANIMALS, NEWBORN; DEXAMETHASONE; GLUCOCORTICOIDS; GROWTH; HYDROCORTISONE; MODELS, ANIMAL; PULMONARY ALVEOLI; RATS; RATS, WISTAR;

EID: 0036100240     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.10108     Document Type: Article

References (33)

1. Prophylactic corticosteroids for preterm birth
2. Meta-analysis of dexamethasone therapy started in the first 15 days of life for prevention of chronic lung disease in premature infants
3. Postnatal steroids: Short-term gain, long-term pain?
4. Glucocorticoids in perinatal medicine: Misguided rockets?
5. Glucocorticoids and lung development in the fetus and preterm infant
6. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants
7. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy
8. Early dexamethasone therapy in preterm infants: A follow-up study
9. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: Outcome of study participants at 1-year adjusted age
10. Dexamethasone administration to newborn mice alters mucosal and muscular morphology in the ileum and modulates IGF-1 localization
11. Postnatal development of alveoli. Regulation and evidence for a critical period in rats
12. Postnatal lung development and its impairment by glucocorticoids
13. Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants
14. Effect of pulse dexamethsone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant
15. Leukotrienes are indicated as mediators of hyperoxia-inhibited alveolarization in newborn rats
16. 2 and a critical period
17. The postnatal growth of the rat lung
18. The changing patterns of the developing lungs of infants
19. Postnatal lung development and its impairment by glucocorticoids
20. Correlation between chemical structure, receptor binding and biological activity of some novel, highly active 16α, 17α-acetal substituted glucocorticoids
21. Lung growth and development during experimental malnutrition
22. Influence of postnatally administered glucocorticoids on rat lung growth
23. Effect of triamcinolone acetonide on the development of the pulmonary airways in the fetal rat
24. Antenatal endotoxin and glucocorticoid effects on lung morphometry and preterm lambs
25. Evidence for independent regulators of organ maturation in fetal rabbits
26. The effects of hydrocortisone on lung structure in fetal lambs
27. Corticosteroids and growth
28. Postnatal treatment with retinoic acid increases the number of pulmonary alveoli in rats
29. Effects of retinoic acid on airspace development and lung collagen in hyperoxia-exposed newborn rats
30. Programmed cell death contributes to postnatal lung development
31. Up-and down-regulation by glucocorticoids of the constitutive expression of the mast cell growth factor stem cell factor by human lung fibroblasts in culture
32. The new BPD: An arrest of lung development
33. Lung development and function in preterm infants in the surfactant treatment era